Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 267

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM

Open access
Hosek, Sybil G., Rudy, Bret, Landovitz, Raphael, Kapogiannis, Bill, Siberry, George, Rutledge, Brandy, Liu, Nancy, Brothers, Jennifer, Mulligan, Kathleen, Zimet, Gregory, Lally, Michelle, Mayer, Kenneth H., Anderson, Peter, Kiser, Jennifer, Rooney, James F., Wilson, Craig M., the Adolescent Trials Network (ATN) for HIV/AIDS Interventions · 2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

Background: Young men who have sex with men (YMSM) are a key population for implementation of preexposure prophylaxis (PrEP) interventions. This open-label study examined adherence to PrEP and assessed sexual behavior among a diverse sample of YMSM in 12 US cities. Methods: Eligible participants were 18- to 22-year-old HIV-uninfected MSM who reported HIV transmission risk behavior in the previous 6 months. Participants were provided daily tenofovir disoproxil fumarate/emtricitabine (Truvada). Study visits occurred at baseline, monthly through week 12, and then quarterly through week 48. Dried blood spots were serially collected for the quantification of tenofovir diphosphate (TFV-DP). Results: Between March and September 2013, 2186 individuals were approached and 400 were found to be preliminarily eligible. Of those 400, 277 were scheduled for an in-person screening visit and 200 were enrolled (mean age = 20.2; 54.5% black, 26.5% Latino). Diagnosis of sexually transmitted infections, including urethral and rectal chlamydial/gonococcal infection and syphilis, at baseline was 22% and remained high across visits. At week 4, 56% of participants had TFV-DP levels consistent with ≥4 pills per week. By week 48, 34% of participants had TFV-DP levels consistent with ≥4 pills per week, with a noticeable drop-off occurring at week 24. Four HIV seroconversions occurred on study (3.29/100 person-years). Condomless sex was reported by >80% of participants, and condomless anal sex with last partner was associated with higher TFV-DP levels. Conclusions: Acceptability of PrEP was high, and most participants achieved protective drug levels during monthly visits. As visit frequency decreased, so did adherence. YMSM in the United States may need PrEP access in youth-friendly settings with tailored adherence support and potentially augmented visit schedules.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qai.0000000000001179

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 267

Metadata

Authors
Hosek, S. G., Rudy, B., Landovitz, R., Kapogiannis, B., Siberry, G., Rutledge, B., Liu, N., Brothers, J., Mulligan, K., Zimet, G., Lally, M., Mayer, K. H., Anderson, P., Kiser, J., Rooney, J. F., Wilson, C. M., & the Adolescent Trials Network (ATN) for HIV/AIDS Interventions
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2017-01-01
Volume
74
Issue
1
Pages
21-29
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2520993191
Cited by
267
References
31
FWCI
33.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. https://app.cochat.ai/papers/10.1097/qai.0000000000001179
The paper
Hosek, S. G., Rudy, B., Landovitz, R., Kapogiannis, B., Siberry, G., Rutledge, B., Liu, N., Brothers, J., Mulligan, K., Zimet, G., Lally, M., Mayer, K. H., Anderson, P., Kiser, J., Rooney, J. F., Wilson, C. M., & the Adolescent Trials Network (ATN) for HIV/AIDS Interventions. (2017). An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000001179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.